GNPDA1

Across TCGA pan-cancer cohorts, GNPDA1 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of GNPDA1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where GNPDA1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types GNPDA1 is over-expressed in tumor, although a few such as COAD and LSCC show the opposite, repressed pattern.

COAD, LSCC, and PDAC are the cancer types where GNPDA1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GNPDA1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	All	−0.358	<.001	8	view →
LSCC	Male	All	−0.173	<.001	8	view →
PDAC	Male	All	+0.448	<.001	6	view →
CCRCC	Male	All	−0.269	<.001	6	view →
LUAD	All	III,IV	−0.182	.006	6	view →
HNSC	Male	IV	+0.133	.021	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

GNPDA1–COAD

Open the COAD breakdown →